Ilex Medical
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine micros… Read more
Ilex Medical (ILX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.068x
Based on the latest financial reports, Ilex Medical (ILX) has a cash flow conversion efficiency ratio of 0.068x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA44.77 Million) by net assets (ILA660.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ilex Medical - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Ilex Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ilex Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ilex Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WestMountain Gold Inc
PINK:WMTN
|
0.114x |
|
Dotz SA
SA:DOTZ3
|
0.027x |
|
DO & CO
BE:DOQ
|
0.238x |
|
Tidewater Midstream and Infrastructure Ltd
PINK:TWMIF
|
-0.058x |
|
Laxmi Cotspin Limited
NSE:LAXMICOT
|
0.025x |
|
Nagreeka Exports Limited
NSE:NAGREEKEXP
|
0.065x |
|
Wawasan Dengkil Holdings Berhad
KLSE:0347
|
0.002x |
|
Jourdan Resources Inc
PINK:JORFF
|
-7.509x |
Annual Cash Flow Conversion Efficiency for Ilex Medical (2008–2024)
The table below shows the annual cash flow conversion efficiency of Ilex Medical from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA646.49 Million | ILA81.63 Million | 0.126x | -2.12% |
| 2023-12-31 | ILA623.51 Million | ILA80.43 Million | 0.129x | +13.41% |
| 2022-12-31 | ILA613.10 Million | ILA69.74 Million | 0.114x | -75.81% |
| 2021-12-31 | ILA575.57 Million | ILA270.68 Million | 0.470x | +14.35% |
| 2020-12-31 | ILA443.54 Million | ILA182.40 Million | 0.411x | +56.71% |
| 2019-12-31 | ILA323.48 Million | ILA84.89 Million | 0.262x | +31.43% |
| 2018-12-31 | ILA293.49 Million | ILA58.60 Million | 0.200x | -30.04% |
| 2017-12-31 | ILA266.15 Million | ILA75.96 Million | 0.285x | +446.57% |
| 2016-12-31 | ILA244.51 Million | ILA12.77 Million | 0.052x | -73.88% |
| 2015-12-31 | ILA225.99 Million | ILA45.17 Million | 0.200x | -48.76% |
| 2014-12-31 | ILA204.60 Million | ILA79.81 Million | 0.390x | +275.55% |
| 2013-12-31 | ILA214.38 Million | ILA22.27 Million | 0.104x | -50.83% |
| 2012-12-31 | ILA259.96 Million | ILA54.92 Million | 0.211x | +17.88% |
| 2011-12-31 | ILA282.99 Million | ILA50.71 Million | 0.179x | -44.23% |
| 2010-12-31 | ILA120.80 Million | ILA38.82 Million | 0.321x | -17.86% |
| 2009-12-31 | ILA127.32 Million | ILA49.81 Million | 0.391x | +47.29% |
| 2008-12-31 | ILA109.44 Million | ILA29.07 Million | 0.266x | -- |